Abiopharma

Arcus Biosciences - Arcus Biosciences’Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer

Calidi Biotherapeutics - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs

Moderna - Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Water Tower Research Highlights Growing Momentum for Ainos Scent-Tech Solutions and Industrial SmellTech Leadership with New High-Impact Partnerships

Elanco Animal Health Inc. - Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference

Kodiak Sciences to Host Investor R&D Day on July 16, 2025

Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’sAssociation International Conference (AAIC®) 2025

Incyte to Report Second Quarter Financial Results

BullFrog AI Unveils BullFrog Data Networks™Solutions Library, Expanding Scalable AI-Powered Biomedical Insight Platform to Large Enterprises

IceCure Announces Commencement of Rights Offering

Kodiak Sciences to Host Investor R&D Day on July 16, 2025